Literature DB >> 23908537

Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting.

Kristina Callis Duffin1, Alice B Gottlieb.   

Abstract

At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in Stockholm, Sweden, dermatology members provided summaries of ongoing work with outcome measures for psoriasis severity. Controversies around the physician global assessment (PGA) were summarized, including discussions of variations and limitations of the static PGA instruments in use. The Psoriasis Outcome Measures project was introduced, with a goal of developing measures for use in clinical trials and practice. This project will follow the Outcome Measures in Rheumatology (OMERACT) process and may become a model for outcome measures of other dermatologic diseases.

Entities:  

Keywords:  OMERACT; OUTCOME MEASURES; PHYSICIAN GLOBAL ASSESSMENT; PSORIASIS; PSORIATIC ARTHRITIS

Mesh：

Year:  2013        PMID： 23908537     DOI： 10.3899/jrheum.130454

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  2 in total

1.  Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).

Authors:  S K Mahil; N Wilson; N Dand; N J Reynolds; C E M Griffiths; R Emsley; A Marsden; I Evans; R B Warren; D Stocken; J N Barker; A D Burden; C H Smith
Journal:  Br J Dermatol       Date:  2019-09-10       Impact factor: 9.302

2.  A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies.

Authors:  Kristina Callis Duffin; Andrew G Bushmakin; Joseph C Cappelleri; Lotus Mallbris; Carla Mamolo
Journal:  BMC Dermatol       Date:  2019-06-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.